22 - 24 January 2018 - Washington, USA

Our Development Consulting team attended this year’s DIA Pharmacovigilance and Risk Management Strategies Conference in Washington DC. The event brings together regulators and industry experts to take an in-depth look at some of the latest issues facing pharmacovigilance and risk management. This year there was particular attention on:

• Challenges with Risk Management for innovative and advanced therapeutics (e.g. immuno-oncology and CAR-T therapies)
• Artificial intelligence in PV case processing 
• Safety and Risk Management with combination products
• Plus EU and FDA updates

We contributed to the programme with our Head of Development, Mark Perrott, presenting alongside Michael Richardson (EU QPPV) from BMS on the benefits and challenges of using digital tools in Risk Minimisation.

If you missed the chance to catch up with us at this meeting and would like to receive our thought leadership pieces on relevant trends and activities in drug safety and regulatory, as well as update you with our latest events and webinars, click here and simply complete the form.

A huge thank you to all who stopped by our table top – we hope to see you all again soon.